C4 Therapeutics, Inc. (CCCC): Shares Outstanding

Annual figures by period end, from SEC filings.

96.91M
As of 2025-12-31
122.91M
As of 2026-06-30
+25.6%
3-year compound annual growth
+17.6%
5-year compound annual growth
2019-12-31: 1.43M2020-12-31: 43.06M2021-12-31: 48.69M2022-12-31: 48.97M2023-12-31: 60.47M2024-12-31: 70.63M2025-12-31: 96.91M96.91M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3196.91M+37.2%2026-02-26, Balance as of period end
2024-12-3170.63M+16.8%2026-02-26, Balance as of period end
2023-12-3160.47M+23.5%2025-02-27, Balance as of period end
2022-12-3148.97M+0.6%2024-02-22, Balance as of period end
2021-12-3148.69M+13.1%2023-02-23, Balance as of period end
2020-12-3143.06Mn/m2022-02-24, Balance as of period end
2019-12-311.43Mn/a2021-03-11, Balance as of period end